Email address
[email protected]Contact number
+1 713 632 8000Chambers Review
Yetter Coleman's group is noted for its extensive experience of advising clients in the burgeoning psychedelics space. The team are called upon to provide counsel on FDA and DEA regulatory submissions, as well as complex disputes in this space.
Work Highlights
- Yetter Coleman acted as co-lead litigator on behalf of AIMS Institute in a lawsuit seeking to reverse denial of petition to reschedule psilocybin entitled AIMS v DEA.
Strengths
Provided by Chambers
"The firm is an excellent boutique litigation firm that routinely handles complex and specialized matters."
"The firm is an excellent boutique litigation firm that routinely handles complex and specialized matters."
Notable Practitioners
Matthew Zorn is a highly respected litigator with considerable experience in the psychedelics and cannabis space. He routinely assists clients in challenges to DEA proposed rules, among other issues.
"Matt is a brilliant litigator and an attorney whom I deeply respect."